Head-To-Head Comparison: Praxsyn (OTCMKTS:PXYN) and InMed Pharmaceuticals (NASDAQ:INM)

Praxsyn (OTCMKTS:PXYN – Get Free Report) and InMed Pharmaceuticals (NASDAQ:INM – Get Free Report) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, institutional ownership, dividends, analyst recommendations, profitability, valuation and risk. Risk and Volatility Praxsyn has a beta of 1.9, suggesting that its stock price is 90% more volatile than the S&P 500. Comparatively, InMed Pharmaceuticals has a beta of 0.95, suggesting that its stock price is 5% less volatile than the S&P 500. Analyst Ratings This is a summary of recent recommendations and price targets for Praxsyn and InMed Pharmaceuticals, as provided by MarketBeat. | Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | | | Praxsyn | 0 | 0 | 0 | 0 | 0.00 | | InMed Pharmaceuticals | 1 | 0 | 0 | 0 | 1.00 | Profitability This table compares Praxsyn and InMed Pharmaceuticals’ net margins, return on equity and return on assets. | Net Margins | Return on Equity | Return on Assets | | | Praxsyn | N/A | N/A | N/A | | InMed Pharmaceuticals | -132.87% | -80.85% | -68.11% | Institutional & Insider Ownership 20.1% of InMed Pharmaceuticals shares are owned by institutional investors. 0.9% of InMed Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Earnings & Valuation This table compares Praxsyn and InMed Pharmaceuticals”s gross revenue, earnings per share (EPS) and valuation. | Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | | | Praxsyn | N/A | N/A | N/A | N/A | N/A | | InMed Pharmaceuticals | $4.94 million | 1.02 | -$8.16 million | ($2.89) | -0.53 | Praxsyn has higher earnings, but lower revenue than InMed Pharmaceuticals. Summary Praxsyn beats InMed Pharmaceuticals on 5 of the 9 factors compared between the two stocks. About Praxsyn Praxsyn Corporation, a health care company, provides medical practitioners with medications and services for their patients. It formulates non-narcotic and non-habit forming medications using therapeutic and preventative agents in the forms of transdermal creams, patches, and oral capsules for pain management, erectile dysfunction, and metabolic therapies. Praxsyn Corporation provides its products to patients covered under the California workers’ compensation system, as well as preferred provider contracts. The company was formerly known as The PAWS Pet Company, Inc. and changed its name to Praxsyn Corporation in March 2014. Praxsyn Corporation was founded in 2005 and is headquartered in Las Vegas, Nevada. About InMed Pharmaceuticals InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, develops a pipeline of prescription-based products. The company operates through two segments, the InMed and the BayMedica. The InMed segment researches and develops cannabinoid-based pharmaceuticals products. The BayMedica segment develops proprietary manufacturing technologies to produce and sell rare cannabinoids for the health and wellness industry. Its prescription-based products include rare cannabinoids and novel cannabinoid analogs for the treatment of diseases with high unmet medical needs. The company’s lead product is INM-755, a cannabinol topical skin cream, completed Phase 2 clinical trial for the treatment of epidermolysis bullosa. It also develops INM-088, which is in preclinical studies for the treatment of glaucoma; and INM-900 for neurodegenerative diseases. In addition, the company offers IntegraSyn, an integrated biosynthesis-based manufacturing approach, for pharmaceutical-grade cannabinoids; and cannabichromene, cannabicitran, cannabidivarin, and tetrahydrocannabivarin. The company was formerly known as Cannabis Technologies Inc. and changed its name to InMed Pharmaceuticals Inc. in October 2014. InMed Pharmaceuticals Inc. was incorporated in 1981 and is headquartered in Vancouver, Canada. Receive News & Ratings for Praxsyn Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Praxsyn and related companies with MarketBeat.com's FREE daily email newsletter.